X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-02-28 | ABCP | Ambase Corp | Barc Investments LLC | 10% | P - Purchase | $0.20 | +44,200,460 | 60,200,460 | +276% | +$8,840,092 | ||||||
2024-03-01 | ABSI | Absci Corp | Redmile Group, LLC | Dir | P - Purchase | $4.50 | +222,222 | 8,253,316 | +3% | +$999,999 | ||||||
M | 2024-03-08 | ACHR | Archer Aviation Inc. | Stellantis N.V. | 10% | P - Purchase | $4.71 | +1,600,000 | 36,251,720 | +5% | +$7,539,040 | |||||
M | 2024-03-04 | ACHR | Archer Aviation Inc. | Stellantis N.V. | 10% | P - Purchase | $4.34 | +3,603,583 | 34,651,720 | +12% | +$15,634,780 | |||||
D | 2024-03-04 | ACHV | Achieve Life Sciences, Inc. | Bencich John | CEO | P - Purchase | $4.59 | +10,000 | 76,724 | +15% | +$45,850 | |||||
D | 2024-03-04 | ACHV | Achieve Life Sciences, Inc. | Stewart Richard Alistair | Exec COB | P - Purchase | $4.59 | +10,000 | 38,501 | +35% | +$45,850 | |||||
M | 2024-03-01 | ACRS | Aclaris Therapeutics, Inc. | Powell Andrew Kenneth William | Dir | P - Purchase | $1.24 | +14,500 | 28,863 | +101% | +$17,955 | |||||
2024-03-11 | ADV | Advantage Solutions Inc. | Pestello Jack Anthony | COO, Branded Services | P - Purchase | $3.87 | +10,000 | 146,279 | +7% | +$38,700 | ||||||
2024-03-04 | ADV | Advantage Solutions Inc. | Peacock David A | CEO | P - Purchase | $3.60 | +15,000 | 1,968,112 | +1% | +$54,026 | ||||||
2024-03-06 | ADV | Advantage Solutions Inc. | Growe Christopher | CFO | P - Purchase | $3.49 | +10,000 | 175,116 | +6% | +$34,868 | ||||||
2024-02-28 | AGFY | Agrify Corp | Chang Raymond Nobu | CEO, COB, 10% | P - Purchase | $0.38 | +1,842,104 | 3,297,221 | +127% | +$700,000 | ||||||
2024-03-15 | AIM | Aim Immunotech Inc. | Equels Thomas K | CEO, Pres | P - Purchase | $0.33 | +75,758 | 716,455 | +12% | +$25,000 | ||||||
2024-03-15 | AIM | Aim Immunotech Inc. | Appelrouth Stewart | Dir | P - Purchase | $0.33 | +90,910 | 239,765 | +61% | +$30,000 | ||||||
2024-03-15 | AIM | Aim Immunotech Inc. | Rodino Peter W III | COO, Secretary, Gen. Counsel | P - Purchase | $0.33 | +37,879 | 181,718 | +26% | +$12,500 | ||||||
2024-03-14 | ALHC | Alignment Healthcare, Inc. | Kao John E | CEO | P - Purchase | $4.82 | +103,000 | 5,468,353 | +2% | +$496,779 | ||||||
2024-02-27 | ALTM | Arcadium Lithium Plc | Marcet Pablo | Dir | P - Purchase | $4.75 | +14,034 | 30,876 | +83% | +$66,662 | ||||||
2024-03-06 | ALTM | Arcadium Lithium Plc | Oris De Roa Fernando | Dir | P - Purchase | $4.89 | +5,000 | 91,000 | +6% | +$24,450 | ||||||
2024-03-15 | ANIX | Anixa Biosciences Inc | Baskies Arnold M | Dir | P - Purchase | $3.63 | +10,000 | 110,000 | +10% | +$36,300 | ||||||
2024-03-15 | ANIX | Anixa Biosciences Inc | Kumar Amit | CEO | P - Purchase | $3.22 | +30,000 | 491,925 | +6% | +$96,600 | ||||||
M | 2024-01-16 | ASPI | Asp Isotopes Inc. | Ryan Robert John Andrew | Dir | P - Purchase | $2.29 | +18,346 | 537,055 | +4% | +$41,992 | |||||
D | 2024-03-15 | AWRE | Aware Inc /ma/ | Eckel Robert A | CEO, Pres | P - Purchase | $1.67 | +13,735 | 342,232 | +4% | +$22,881 | |||||
M | 2024-02-20 | BBGI | Beasley Broadcast Group Inc | Beasley Brian E | COO, 10% | P - Purchase | $0.88 | +13,000 | 364,236 | +4% | +$11,500 | |||||
2024-03-11 | BCOV | Brightcove Inc | Edenbrook Capital, LLC | 10% | P - Purchase | $1.87 | +33,300 | 6,405,437 | +1% | +$62,388 | ||||||
2024-02-27 | BCOV | Brightcove Inc | Debevoise Marc | CEO | P - Purchase | $2.03 | +25,000 | 1,175,962 | +2% | +$50,750 | ||||||
M | 2024-02-23 | BCOV | Brightcove Inc | Edenbrook Capital, LLC | 10% | P - Purchase | $1.86 | +41,747 | 6,372,137 | +1% | +$77,667 | |||||
M | 2024-02-20 | BENF | Beneficient | Cangany Peter T Jr | Dir | P - Purchase | $0.26 | +400,000 | 477,500 | +516% | +$102,000 | |||||
D | 2024-03-04 | BKKT | Bakkt Holdings, Inc. | Intercontinental Exchange, Inc. | 10% | P - Purchase | $0.87 | +2,762,009 | 7,476,345 | +59% | +$2,394,662 | |||||
2024-03-13 | BLND | Blend Labs, Inc. | Jafari Amir | Head of Finance, Admin. | P - Purchase | $3.00 | +5,555 | 396,451 | +1% | +$16,665 | ||||||
M | 2024-02-29 | BRN | Barnwell Industries Inc | Horowitz Joshua | Dir | P - Purchase | $2.27 | +11,663 | 295,592 | +4% | +$26,427 | |||||
2024-03-06 | CATX | Perspective Therapeutics, Inc. | Lantheus Alpha Therapy, LLC | 10% | P - Purchase | $0.95 | +60,431,039 | 116,773,394 | +107% | +$57,409,487 | ||||||
2024-03-14 | CLOV | Clover Health Investments, Corp. /de | Loengard Anna U | Dir | P - Purchase | $0.73 | +150,625 | 565,266 | +36% | +$109,956 | ||||||
M | 2024-03-12 | COMM | Commscope Holding Company, Inc. | Krause L William | Dir | P - Purchase | $1.59 | +149,427 | 320,000 | +88% | +$238,107 | |||||
2024-03-05 | COMM | Commscope Holding Company, Inc. | Watts Claudius E. IV | Dir | P - Purchase | $1.05 | +15,000 | 951,830 | +2% | +$15,770 | ||||||
M | 2024-03-13 | COOK | Traeger, Inc. | Andrus Jeremy | CEO | P - Purchase | $2.35 | +396,689 | 16,032,474 | +3% | +$933,006 | |||||
D | 2024-03-15 | CORZ | Core Scientific, Inc./Tx | Rozov Yadin | Dir | P - Purchase | $3.07 | +80,000 | 80,000 | New | +$245,968 | |||||
2024-03-15 | CORZ | Core Scientific, Inc./Tx | Weiss Eric Stanton | Dir | P - Purchase | $3.03 | +15,000 | 15,000 | New | +$45,396 | ||||||
2024-03-15 | CORZ | Core Scientific, Inc./Tx | Sullivan Adam Taylor | CEO | P - Purchase | $3.06 | +65,300 | 93,753 | +230% | +$199,962 | ||||||
2024-02-16 | COSM | Cosmos Health Inc. | Siokas Grigorios | CEO, 10% | P - Purchase | $0.83 | +60,000 | 1,394,597 | +4% | +$49,806 | ||||||
2024-03-13 | CRMD | Cormedix Inc. | Todisco Joseph | CEO | P - Purchase | $3.74 | +13,561 | 352,839 | +4% | +$50,718 | ||||||
2024-02-16 | CTHR | Charles & Colvard Ltd | Sykes Ollin B | Dir | P - Purchase | $0.37 | +125,000 | 3,108,285 | +4% | +$46,738 | ||||||
2024-02-22 | CTHR | Charles & Colvard Ltd | O'Connell Don | Pres, CEO | P - Purchase | $0.34 | +30,000 | 692,100 | +5% | +$10,164 | ||||||
2024-02-22 | CTHR | Charles & Colvard Ltd | Sykes Ollin B | Dir, 10% | P - Purchase | $0.33 | +107,500 | 3,215,785 | +3% | +$35,024 | ||||||
M | 2024-02-28 | CTHR | Charles & Colvard Ltd | Sykes Ollin B | Dir, 10% | P - Purchase | $0.38 | +44,940 | 3,260,725 | +1% | +$17,287 | |||||
2024-02-28 | CTV | Innovid Corp. | Netter Zvika | CEO | P - Purchase | $1.84 | +25,000 | 7,017,915 | 0% | +$45,970 | ||||||
2024-02-29 | CTV | Innovid Corp. | Callini Anthony | CFO | P - Purchase | $1.82 | +11,000 | 499,750 | +2% | +$20,061 | ||||||
2024-03-08 | DBVT | Dbv Technologies S.A. | Tasse Daniel | CEO | P - Purchase | $0.83 | +17,094 | 17,094 | New | +$14,188 | ||||||
2024-02-22 | DC | Dakota Gold Corp. | Schroeder Alice D. | Dir | P - Purchase | $1.96 | +7,410 | 256,179 | +3% | +$14,521 | ||||||
2024-03-15 | DCGO | Docgo Inc. | Katz Steven | Dir | P - Purchase | $3.64 | +13,500 | 69,534 | +24% | +$49,140 | ||||||
2024-03-14 | DCGO | Docgo Inc. | Rosenberg Norman | CFO, Treasurer | P - Purchase | $3.61 | +10,000 | 407,419 | +3% | +$36,100 | ||||||
2024-03-14 | DCGO | Docgo Inc. | Burdiek Michael J | Dir | P - Purchase | $3.61 | +10,000 | 571,595 | +2% | +$36,100 | ||||||
2024-03-15 | DTC | Solo Brands, Inc. | Metz Christopher T | Pres, CEO | P - Purchase | $2.27 | +100,000 | 100,000 | New | +$226,560 | ||||||
M | 2024-02-26 | EMMA | Emmaus Life Sciences, Inc. | Lee Willis C | Co-Pres, COO | P - Purchase | $0.13 | +115,200 | 795,718 | +17% | +$14,694 | |||||
2024-02-23 | EOD | Allspring Global Dividend Opportunity Fund | Fioramonti Vincent J | Portfolio Manager | P - Purchase | $4.54 | +4,000 | 22,000 | +22% | +$18,152 | ||||||
2024-03-07 | EVC | Entravision Communications Corp | Christenson Michael J | CEO | P - Purchase | $1.67 | +100,000 | 1,402,170 | +8% | +$167,250 | ||||||
2024-03-06 | EVLV | Evolv Technologies Holdings, Inc. | Gonzales David Mounts | Dir | P - Purchase | $3.86 | +50,000 | 50,000 | New | +$193,000 | ||||||
2024-02-22 | EXFY | Expensify, Inc. | McLaughlin Steven J. | 10% | P - Purchase | $1.59 | +182,941 | 10,313,305 | +2% | +$290,876 | ||||||
2024-03-08 | EYEN | Eyenovia, Inc. | Grant Stuart M. | 10% | P - Purchase | $1.58 | +10,717 | 5,280,715 | 0% | +$16,911 | ||||||
2024-03-07 | FGEN | Fibrogen Inc | Wettig Thane | CEO | P - Purchase | $1.91 | +50,000 | 471,178 | +12% | +$95,470 | ||||||
2024-03-12 | FLNT | Fluent, Inc. | Schulke Ryan | Chief Strategy Officer, 10% | P - Purchase | $0.59 | +20,000 | 10,774,528 | 0% | +$11,858 | ||||||
M | 2024-03-13 | FLNT | Fluent, Inc. | Schulke Ryan | Chief Strategy Officer, 10% | P - Purchase | $0.53 | +31,000 | 10,805,528 | 0% | +$16,427 | |||||
M | 2024-03-04 | FLNT | Fluent, Inc. | Schulke Ryan | Chief Strategy Officer, 10% | P - Purchase | $0.55 | +30,000 | 10,734,528 | 0% | +$16,510 | |||||
M | 2024-03-11 | FRTX | Fresh Tracks Therapeutics, Inc. | Exploration Capital, LLC | 10% | P - Purchase | $0.92 | +16,329 | 1,010,842 | +2% | +$14,951 | |||||
M | 2024-02-20 | FRTX | Fresh Tracks Therapeutics, Inc. | Exploration Capital, LLC | 10% | P - Purchase | $0.89 | +77,404 | 974,404 | +9% | +$68,665 | |||||
2024-02-26 | FRTX | Fresh Tracks Therapeutics, Inc. | Exploration Capital, LLC | 10% | P - Purchase | $0.90 | +20,109 | 994,513 | +2% | +$18,098 | ||||||
2024-03-04 | FSP | Franklin Street Properties Corp /ma/ | Hansen Brian N | Dir | P - Purchase | $2.33 | +50,000 | 1,298,720 | +4% | +$116,320 | ||||||
M | 2024-02-16 | GEG | Great Elm Group, Inc. | Reese Jason W. | See remarks, 10% | P - Purchase | $1.95 | +13,533 | 13,174,307 | 0% | +$26,451 | |||||
M | 2024-03-11 | GEG | Great Elm Group, Inc. | Reese Jason W. | See remarks, 10% | P - Purchase | $1.93 | +19,506 | 13,481,309 | 0% | +$37,709 | |||||
M | 2024-02-27 | GEG | Great Elm Group, Inc. | Reese Jason W. | See remarks, 10% | P - Purchase | $1.92 | +124,090 | 13,427,693 | +1% | +$238,539 | |||||
M | 2024-03-14 | GEG | Great Elm Group, Inc. | Reese Jason W. | See remarks, 10% | P - Purchase | $1.99 | +11,097 | 13,514,360 | 0% | +$22,129 | |||||
M | 2024-03-05 | GEG | Great Elm Group, Inc. | Reese Jason W. | See remarks, 10% | P - Purchase | $1.95 | +14,607 | 13,451,527 | 0% | +$28,476 | |||||
M | 2024-02-21 | GOVX | Geovax Labs, Inc. | Dodd David A | Pres, CEO | P - Purchase | $2.27 | +8,729 | 18,661 | +88% | +$19,781 | |||||
M | 2024-02-16 | GREE | Greenidge Generation Holdings Inc. | Kovler Jordan | CEO | P - Purchase | $3.96 | +3,500 | 12,000 | +41% | +$13,852 | |||||
2024-03-11 | GROV | Grove Collaborative Holdings, Inc. | Yurcisin Jeffrey Michael | Pres, CEO | P - Purchase | $1.85 | +5,406 | 25,823 | +26% | +$10,001 | ||||||
2024-03-11 | GROV | Grove Collaborative Holdings, Inc. | Replogle John B | Dir | P - Purchase | $1.93 | +25,900 | 349,658 | +8% | +$49,987 | ||||||
2024-03-08 | GROV | Grove Collaborative Holdings, Inc. | Yurcisin Jeffrey Michael | Pres, CEO | P - Purchase | $1.94 | +10,417 | 20,417 | +104% | +$20,238 | ||||||
2024-03-08 | GROV | Grove Collaborative Holdings, Inc. | Landesberg Stuart | Executive Chairman | P - Purchase | $2.15 | +10,800 | 1,089,172 | +1% | +$23,220 | ||||||
M | 2024-01-29 | GRTX | Galera Therapeutics, Inc. | Schneid Yair | 10% | P - Purchase | $0.18 | +932,402 | 8,043,203 | +13% | +$166,417 | |||||
M | 2024-03-11 | GSAT | Globalstar, Inc. | Lynch James F | Dir | P - Purchase | $1.43 | +1,320,000 | 12,514,388 | +12% | +$1,887,666 | |||||
2024-03-13 | GSAT | Globalstar, Inc. | Lynch James F | Dir | P - Purchase | $1.46 | +660,000 | 13,174,388 | +5% | +$960,300 | ||||||
M | 2024-03-07 | GSAT | Globalstar, Inc. | Lynch James F | Dir | P - Purchase | $1.32 | +1,320,000 | 11,194,388 | +13% | +$1,747,614 | |||||
2024-02-15 | HLGN | Heliogen, Inc. | Nant Capital, LLC | 10% | P - Purchase | $1.52 | +442,298 | 1,455,593 | +44% | +$672,072 | ||||||
M | 2024-03-14 | HLLY | Holley Inc. | Clempson Graham | Dir | P - Purchase | $4.20 | +100,000 | 104,775 | >999% | +$420,101 | |||||
DM | 2024-01-03 | HMLA | Himalaya Technologies, Inc | Grover Vikram P | CEO, CFO, Secretary, 10% | P - Purchase | $0.00 | +24,390,004 | 24,390,004 | New | +$25,680 | |||||
DM | 2024-01-03 | HMLA | Himalaya Technologies, Inc | Grover Vikram P | CEO, CFO, Secretary, 10% | P - Purchase | $0.00 | +24,390,004 | 24,390,004 | New | +$25,680 | |||||
DM | 2024-01-03 | HMLA | Himalaya Technologies, Inc | Grover Vikram P | CEO, CFO, Secretary, 10% | P - Purchase | $0.00 | +24,390,004 | 24,390,004 | New | +$25,680 | |||||
2024-02-20 | INM | Inmed Pharmaceuticals Inc. | Adams Eric A | Pres, CEO | P - Purchase | $0.36 | +41,600 | 43,959 | >999% | +$14,922 | ||||||
2024-02-21 | INM | Inmed Pharmaceuticals Inc. | Hull Andrew | Dir | P - Purchase | $0.39 | +37,500 | 38,258 | >999% | +$14,625 | ||||||
M | 2024-03-04 | LAB | Standard Biotools Inc. | Casdin Partners Master Fund, L.P. | Dir, 10% | P - Purchase | $2.57 | +251,403 | 23,093,703 | +1% | +$646,169 | |||||
2024-03-04 | LIFW | Msp Recovery, Inc. | Ruiz John Hasan | CEO, 10% | P - Purchase | $1.14 | +438,596 | 912,786 | +92% | +$499,999 | ||||||
2024-03-12 | LPSN | Liveperson Inc | Wesemann William | Dir | P - Purchase | $1.00 | +100,000 | 374,835 | +36% | +$100,000 | ||||||
2024-03-15 | LSF | Laird Superfood, Inc. | Naylor Maile | Dir | P - Purchase | $2.27 | +8,850 | 91,807 | +11% | +$20,049 | ||||||
2024-03-15 | LSF | Laird Superfood, Inc. | Barker Geoffrey T | Dir | P - Purchase | $2.79 | +50,000 | 179,057 | +39% | +$139,469 | ||||||
2024-02-16 | LTRX | Lantronix Inc | Steele Christa | Dir | P - Purchase | $4.25 | +11,630 | 11,630 | New | +$49,428 | ||||||
2024-02-26 | LUMN | Lumen Technologies, Inc. | Glenn T Michael | Dir | P - Purchase | $1.47 | +50,000 | 349,162 | +17% | +$73,300 | ||||||
2024-03-01 | LUMN | Lumen Technologies, Inc. | Siegel Laurie | Dir | P - Purchase | $1.60 | +30,000 | 224,452 | +15% | +$47,997 | ||||||
D | 2024-03-14 | MAIA | Maia Biotechnology, Inc. | Chaouki Steven M | Dir | P - Purchase | $1.17 | +34,641 | 88,891 | +64% | +$40,530 | |||||
D | 2024-03-14 | MAIA | Maia Biotechnology, Inc. | Louie Ngar Yee | Dir | P - Purchase | $1.17 | +170,940 | 1,147,524 | +18% | +$200,000 | |||||
D | 2024-03-14 | MAIA | Maia Biotechnology, Inc. | Smith Stan | Dir | P - Purchase | $1.17 | +170,940 | 857,568 | +25% | +$200,000 | |||||
D | 2024-03-14 | MAIA | Maia Biotechnology, Inc. | Luput Cristian | Dir | P - Purchase | $1.17 | +69,282 | 367,350 | +23% | +$81,060 | |||||
2024-02-21 | MGLD | Marygold Companies, Inc. | Nicholas & Melinda Gerber Living Trust | CEO, 10% | P - Purchase | $1.11 | +13,751 | 18,263,766 | 0% | +$15,236 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |